Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/36087
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMariscalco, Giovanni-
dc.contributor.authorMariani, S.-
dc.contributor.authorBichi, S.-
dc.contributor.authorBiondi, A.-
dc.contributor.authorBlasio, A.-
dc.contributor.authorBorsani, Paolo-
dc.contributor.authorCorti, F.-
dc.contributor.authorDe Chiara, B.-
dc.contributor.authorGherli, Riccardo-
dc.contributor.authorLeva, C.-
dc.contributor.authorRusso, C. F.-
dc.contributor.authorTasca, G.-
dc.contributor.authorVanelli, P.-
dc.contributor.authorAlfieri, O.-
dc.contributor.authorAntona, C.-
dc.contributor.authorDi Credico, G.-
dc.contributor.authorEsposito, G.-
dc.contributor.authorGamba, A.-
dc.contributor.authorMartinelli, L.-
dc.contributor.authorMenicanti, L.-
dc.contributor.authorPaolini, G.-
dc.contributor.authorBeghi, C.-
dc.date.accessioned2015-12-18T09:58:59Z-
dc.date.available2015-12-18T09:58:59Z-
dc.date.issued2015-
dc.identifier.citationJournal of Cardiothoracic Surgery, 2015, 10 (1), 169en
dc.identifier.urihttp://www.cardiothoracicsurgery.org/content/10/1/169en
dc.identifier.urihttp://hdl.handle.net/2381/36087-
dc.description.abstractBACKGROUND: The Trifecta aortic bioprosthesis (St. Jude Medical, Inc., St. Paul, MN, USA) is a stented pericardial heart valve with excellent preliminary results. Aim of the study was to evaluate its early clinical and hemodynamic performances in a multicenter regional registry. METHODS: Between January 2011 and June 2012, 178 consecutive patients undergoing aortic valve replacement with the Trifecta bioprosthesis were prospectively enrolled at 9 Italian centers. Clinical and echocardiographic data were collectedat discharge, 6-months and at 1-year postoperatively. RESULTS: The average age was 75.4 ± 7.7 years,and 95 (53 %) were men. Indication for valve replacement included stenosis in 123 patients (69 %), mixed lesions in 25 (14 %), and regurgitation in 30 (17 %). Ninety-three (52 %) patients were in NYHA functional class III/ IV. Hospital mortality accounted for 5 (2.8 %) patients. No valve-related perioperative complications were encountered. Median follow-up was 20.5 months (range: 1-34). Early (≤6 months) complications included one thromboembolic event, one major bleeding, and 3 endocarditis (2 explants). Two late (>6 months) thromboembolic events and two endocarditis (1 explant) were registered. No valve thrombosis or structural deterioration were observed after discharge. At 30-months, freedom from all-cause mortality was 87 %, freedom from valve-related mortality 99.4 %, freedom from endocarditis 97.5 %, and freedom from valve explants 98 %. At 1-year, mean gradients ranged from 8 to 16 mmHg, and effective orifice area indexes from 1.0 to 1.2 cm(2)/m(2) for valve sizes from 19 to27 mm, respectively. No patients had severe prosthesis-patient mismatch. CONCLUSIONS: Trifecta bioprosthesis provided favourable clinical and hemodynamic results over time.en
dc.language.isoenen
dc.publisherBioMed Centralen
dc.relation.urihttp://www.ncbi.nlm.nih.gov/pubmed/26589286-
dc.rightsCopyright © 2015 Mariscalco et al. Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en
dc.subjectAortic valve replacementen
dc.subjectBiomaterialsen
dc.subjectHeart valve bioprosthesisen
dc.subjectHeart valve replacementen
dc.titleSt. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registryen
dc.typeJournal Articleen
dc.identifier.doi10.1186/s13019-015-0379-6-
dc.identifier.eissn1749-8090-
dc.identifier.pii10.1186/s13019-015-0379-6-
dc.description.statusPeer-revieweden
dc.description.versionPublisher Versionen
dc.type.subtypeJournal Article-
pubs.organisational-group/Organisationen
pubs.organisational-group/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGYen
pubs.organisational-group/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicineen
pubs.organisational-group/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Cardiovascular Sciencesen
Appears in Collections:Published Articles, Dept. of Cardiovascular Sciences

Files in This Item:
File Description SizeFormat 
St. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry..pdfPublished (publisher PDF)856.95 kBAdobe PDFView/Open


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.